Form 8-K ZIMMER BIOMET HOLDINGS, For: Oct 30

Go back to Form 8-K ZIMMER BIOMET HOLDINGS, For: Oct 30

Zimmer Biomet (ZBH) PT Raised to $117 at Truist Securities

October 31, 2024 12:37 PM EDT

Truist Securities analyst Richard Newitter raised the price target on Zimmer Biomet (NYSE: ZBH) to $117.00 (from $112.00) while maintaining a Hold rating.

The analyst comments "ZBH's 3Q cc rev beat offset by ~90bps op margin miss; in-line EPS benefited from non-operating items and... More

Oppenheimer Reiterates Outperform Rating on Zimmer Biomet (ZBH)

October 30, 2024 4:28 PM EDT

Oppenheimer analyst Steven Lichtman reiterated an Outperform rating and $135.00 price target on Zimmer Biomet (NYSE: ZBH).

The analyst comments "3Q24 sales of $1.824B (+4.1% constant-currency) outpaced our/Street's $1.791B/$1.795B on less ERP headwind than expected and better than expected underlying performance, particularly in SET. Knees... More